Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation). It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.
The Richtopian Vision
- 5 Business Lessons From the "Corporate Scapegoat" Who Lost Five-Billion Euros
- 11 Amazing Examples of Disruptive Technology
- 17 Great Examples of Effective Leadership and Strategy
- Workplace Culture: How to Encourage Collaboration
- What Is Social Marketing? And How Does It Work?
- Great British Pound Notes & People Who've Appeared On Them ...
- 3 Reasons You Should Buy Gold (And 3 Reasons You Shouldn't)
- What Do the Super-Rich Spend Their Money On? (Infographic Included)
- Analytical Thinking: 8 Natural Talents Leading to Action
- Five Fundamental Principles From Adam Grant's "Give and Take" Book
Women in Leadership
Join Our Newsletter
- 3,037,042 all-time readers